Literature DB >> 9787156

Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny.

M N Dworzak1, G Fritsch, G Fröschl, D Printz, H Gadner.   

Abstract

Terminal deoxynucleotidyl transferase (TdT)-positive cells in human bone marrow (BM) are a phenotypically inhomogeneous population of precursor cells. In their majority, these TdT+ cells are unambiguously committed to the B lineage, as evidenced by CD19 expression. However, TdT+ precursors that lack CD19 also exist and these may encompass a differentiation potential for the B as well as for other lineages. Because recent data suggested that CD19 expression is not the earliest differentiation event in B-cell ontogeny, we sought to reevaluate TdT+ lymphoid precursors in pediatric BM to define the phenotypic denominator of B-lineage affiliation upstream of CD19. Using four-color flow cytometry, we focused on the assessment of the CD79a antigen, which is highly B-cell specific and which may also be expressed very early in B-cell ontogeny. We found that a majority of TdT+ cells coexpressed CD19 and CD79a in addition to CD10 and CD34, whereas, in all investigated samples, some TdT+ precursors lacked CD19 but expressed CD79a, which suggestively indicates also their B-lineage affiliation. In contrast to the CD19(+) precursors, which were usually CD10(hi) and CD79b+, these CD19(-)CD79a+ putative B-cell precursors preferentially expressed CD10 at low levels and were CD79b+ in only 41%. About 17% of these TdT+CD19(-)CD79a+ precursors also coexpressed CD33 and CD7, but not myeloperoxidase, CD14, or cytoplasmic CD3, which is discussed in the light of cellular activation rather than lineage promiscuity. Our data confirm that the earliest differentiation stages of B cells can be dissected upon expression of the lineage antigens CD79a and CD19 and imply that CD79a is earlier expressed than CD19. This raises the chance to follow the sequential events heralding B-cell commitment in the most immature precursors by correlating phenotypic and genetic differentiation markers. Copyright 1998 by The American Society of Hematology

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787156

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Shortening the immunodeficient period after hematopoietic stem cell transplantation.

Authors:  Isabelle André-Schmutz; Emmanuelle Six; Delphine Bonhomme; Julien Rouiller; Liliane Dal Cortivo; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

2.  Human B-cell and progenitor stages as determined by probability state modeling of multidimensional cytometry data.

Authors:  C Bruce Bagwell; Beth L Hill; Brent L Wood; Paul K Wallace; Muaz Alrazzak; Abigail S Kelliher; Frederic I Preffer
Journal:  Cytometry B Clin Cytom       Date:  2015-05-23       Impact factor: 3.058

Review 3.  Role of the BCR complex in B cell development, activation, and leukemic transformation.

Authors:  Susan R Rheingold; Valerie I Brown; Junjie Fang; Jenny M Kim; Stephan A Grupp
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Flowcytometric comparative analysis in acute leukemias between Indian and proposed minimal screening panel.

Authors:  Srishti Gupta; Tathagata Chatterjee; Sanjeevan Sharma; Ajay Sharma; Prosenjit Ganguly; Jasjit Singh; Satyaranjan Das
Journal:  Med J Armed Forces India       Date:  2016-03-29

Review 5.  Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin.

Authors:  Andrew J Cowan; George S Laszlo; Elihu H Estey; Roland B Walter
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

6.  Profiling the Atlantic Salmon IgM+ B Cell Surface Proteome: Novel Information on Teleost Fish B Cell Protein Repertoire and Identification of Potential B Cell Markers.

Authors:  Ma Michelle D Peñaranda; Ingvill Jensen; Linn G Tollersrud; Jack-Ansgar Bruun; Jorunn B Jørgensen
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

7.  A human postnatal lymphoid progenitor capable of circulating and seeding the thymus.

Authors:  Emmanuelle M Six; Delphine Bonhomme; Marta Monteiro; Kheira Beldjord; Monika Jurkowska; Corinne Cordier-Garcia; Alexandrine Garrigue; Liliane Dal Cortivo; Benedita Rocha; Alain Fischer; Marina Cavazzana-Calvo; Isabelle André-Schmutz
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

8.  Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.

Authors:  Dror Luger; Yu-An Yang; Asaf Raviv; Douglas Weinberg; Subhadra Banerjee; Min-Jung Lee; Jane Trepel; Li Yang; Lalage M Wakefield
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression.

Authors:  Jae Won Choi; Young Jae Kim; Kyung A Yun; Chong Hyun Won; Mi Woo Lee; Jee Ho Choi; Sung Eun Chang; Woo Jin Lee
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.